Company / Operating Cash Flow per Share
Whitehawk Therapeutics, Inc. Operating Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$2.41
FY2025
5-year range
-$8.97 / -$2.03
FY2021-FY2025
Trend
+0.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 8 years, ranging from $-8.97 in FY2022 to $-0.14 in FY2019.
Based on SEC 10-K filings.
-2.41 in FY2025.
Declined from $-2.03 to $-2.41 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 0.7% year-over-year.
- Peak operating cash flow per share was recorded in FY2019.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.41 | +0.7% |
| FY2024 | -$2.43 | -19.6% |
| FY2023 | -$2.03 | +77.4% |
| FY2022 | -$8.97 | -79.5% |
| FY2021 | -$5.00 | -750.1% |
| FY2020 | -$0.59 | -310.7% |
| FY2019 | -$0.14 | +79.5% |
| FY2018 | -$0.70 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026